Goldman Sachs Group Inc Phibro Animal Health Corp Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 244,242 shares of PAHC stock, worth $5.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,242
Previous 343,269 28.85%
Holding current value
$5.5 Million
Previous $7.72 Million 33.59%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$20.89 - $25.55 $2.07 Million - $2.53 Million
-99,027 Reduced 28.85%
244,242 $5.13 Million
Q3 2024

Nov 14, 2024
BUY
$16.39 - $22.5 $1.91 Million - $2.62 Million
116,334 Added 51.26%
343,269 $7.72 Million
Q2 2024

Aug 13, 2024
BUY
$12.44 - $18.55 $56,191 - $83,790
4,517 Added 2.03%
226,935 $3.81 Million
Q1 2024

May 15, 2024
BUY
$10.63 - $13.68 $288,381 - $371,124
27,129 Added 13.89%
222,418 $2.88 Million
Q4 2023

Feb 13, 2024
BUY
$9.59 - $12.91 $408,783 - $550,301
42,626 Added 27.92%
195,289 $2.26 Million
Q3 2023

May 14, 2024
SELL
$12.43 - $15.29 $529,841 - $651,751
-42,626 Reduced 21.83%
152,663 $1.95 Million
Q3 2023

Nov 14, 2023
SELL
$12.43 - $15.29 $29,832 - $36,696
-2,400 Reduced 1.55%
152,663 $1.95 Million
Q2 2023

May 14, 2024
SELL
$12.92 - $15.89 $2.82 Million - $3.46 Million
-217,982 Reduced 58.43%
155,063 $2.12 Million
Q2 2023

Aug 14, 2023
SELL
$12.92 - $15.89 $2.82 Million - $3.46 Million
-217,982 Reduced 58.43%
155,063 $2.12 Million
Q1 2023

May 14, 2024
SELL
$13.67 - $16.37 $80,830 - $96,795
-5,913 Reduced 1.56%
373,045 $5.72 Million
Q1 2023

May 11, 2023
SELL
$13.67 - $16.37 $80,830 - $96,795
-5,913 Reduced 1.56%
373,045 $5.72 Million
Q4 2022

May 14, 2024
BUY
$12.05 - $15.14 $286,814 - $360,362
23,802 Added 6.7%
378,958 $5.08 Million
Q4 2022

Feb 13, 2023
BUY
$12.05 - $15.14 $286,814 - $360,362
23,802 Added 6.7%
378,958 $5.08 Million
Q3 2022

May 14, 2024
SELL
$12.82 - $20.22 $3.48 Million - $5.48 Million
-271,081 Reduced 43.29%
355,156 $4.72 Million
Q3 2022

Nov 10, 2022
SELL
$12.82 - $20.22 $3.48 Million - $5.48 Million
-271,081 Reduced 43.29%
355,156 $4.72 Million
Q2 2022

May 14, 2024
BUY
$17.89 - $20.47 $7.71 Million - $8.82 Million
430,948 Added 220.67%
626,237 $12 Million
Q2 2022

Aug 15, 2022
SELL
$17.89 - $20.47 $1.06 Million - $1.21 Million
-59,233 Reduced 8.64%
626,237 $12 Million
Q1 2022

May 16, 2022
BUY
$18.39 - $21.85 $185,095 - $219,920
10,065 Added 1.49%
685,470 $13.7 Million
Q4 2021

Feb 14, 2022
BUY
$18.96 - $22.76 $672,435 - $807,206
35,466 Added 5.54%
675,405 $13.8 Million
Q3 2021

Nov 10, 2021
BUY
$20.59 - $30.01 $13.2 Million - $19.2 Million
639,939 New
639,939 $13.8 Million

Others Institutions Holding PAHC

# of Institutions
176
Shares Held
20.7M
Call Options Held
0
Put Options Held
0
View Full List

About PHIBRO ANIMAL HEALTH CORP

PAHC Quotes by TradingView
  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $458M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email